New Market Study, "Russia Pharmaceuticals & Healthcare Report Q2 2013", Has Been Published
Russia's pharmaceutical market continues to be one of the most attractive in the Emerging Europe region, primarily due to its sheer market size, growing economy and increasing government investment in healthcare. The main transformation in the market over the last decade has been the growth of the state's role, both in establishing an industrial policy and investing in production for the first time since the end of the Soviet Union. Key drivers of growth for pharmaceuticals include programmes to fund...
View full press release